Nitto Denko to apply for clinical trials of nucleic acid drugs for pulmonary fibrosis
Through previous studies, organ fibrosis has been related to the presence of stellate cells, and the ND-L02-s0201 siRNA drug will suppress the expression of HSP47 genes highly expressed in activated stellate cells, thus cutting fibrosis. Nitto Denko plans to submit a clinical trial for early 2017. The company also develops ND-L02-s0201 which targets liver cirrhosis. […]